Does prophylactic octreotide benefit patients undergoing elective pancreatic resection?
Open Access
- 1 May 1999
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 3 (3) , 223-224
- https://doi.org/10.1016/s1091-255x(99)80063-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prospective, Randomized Trial of Octreotide to Prevent Pancreatic Fistula After Pancreaticoduodenectomy for Malignant DiseaseAnnals of Surgery, 1997
- Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990sAnnals of Surgery, 1997
- A Prospective Randomized Trial of Pancreaticogastrostomy Versus Pancreaticojejunostomy After PancreaticoduodenectomyAnnals of Surgery, 1995
- Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitisBritish Journal of Surgery, 1995
- Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized clinical trialSurgery, 1995
- Efficacy of octreotide in the prevention of complications of elective pancreatic surgeryBritish Journal of Surgery, 1994
- Role of octreotide in the prevention of postoperative complications following pancreatic resectionThe American Journal of Surgery, 1992
- Effect of a New Somatostatin Analogue on Pancreatic Function in Healthy VolunteersPancreas, 1986
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- [Prevention of postoperative pancreatic complications following duodenopancreatectomy using somatostatin].1979